MassDevice

Medtronic reports 3-year blood pressure reductions with Symplicity Spyral RDN

Medtronic (NYSE: MDT) today announced new long-term results from its final report of the SPYRAL HTN-ON MED trial.
Le Lézard

Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions

Medtronic plc , a global leader in healthcare technology, today announced new, long-term results from its final report of the SPYRAL HTN-ON MED randomized clinical trial, showing that patients treated ...
WFMZ-TV

GoFundMe set up for family of couple fatally shot in Palmer Twp.

PALMER TWP., Pa. - A GoFundMe page has been started to help the family of the couple from Northampton County who authorities say were fatally shot by their son-in-law. Robert and Gretchen Ackerman ...
BMJ Open

Active versus sham transcranial pulsed electromagnetic field headband treatment for major depression: protocol for a double-blinded randomised trial

Introduction A substantial number of patients with major depressive disorder experience non-remission despite treatment with psychotherapy and several antidepressant drugs. This has increased the ...